Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Franklin Mutual Global Discovery Fund Class A (TEDIX)

31.45
Net Asset Value
+0.87%
1 Day
-4.15%
Year-to-Date
Overall Morningstar Rating
World stock
Style or Category
5.75
Sales Expenses
1.29%
Expense Ratio
Low
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund invests primarily in equity securities (including securities convertible into, or that the investment manager expects to be exchanged for, common or preferred stock) of U.S. and foreign companies that the investment manager believes are available at market prices less than their value based on certain recognized or objective criteria (intrinsic value). It invests primarily in undervalued securities (securities trading at a discount to intrinsic value). The managers expect to invest substantially and potentially up to 100% of its assets in foreign securities.

Performance

1 month-7.96% 3 years+9.46%
3 months-9.31% 5 years+8.53%
1 year-5.33% Since inception+9.95%
Data through --

Peer Comparisonvs. World stock

 TEDIXCategory
Performance 5-yr return+8.53%+12.29%
Expense ratio1.29%1.37%
Risk 5 year sharpe ratio1.010.84
Net assets$26.8B$1.3B
Average market cap$43.6B$37.4B
Average P/E16.718.6
Portfolio turnover24%24%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFranklin Templeton Investments
Fund manager & tenurePeter Langerman / 5 Years
Minimal initial investment$1,000.00
Minimum IRA investment$250.00

Holdings

U.S. stock48.30%
International stock39.98%
Cash7.70%
Fixed income4.02%
Other0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 21.95%
Financial service 19.30%
Industrial materials 11.80%
Healthcare 11.19%
Telecommunication 7.46%
Top 10 Holdings
Portfolio weighting
MRK Merck1.98%
MSFT Microsoft1.95%
AAPL Apple1.67%
WFC Wells Fargo1.60%
TEVA Teva Pharmaceutical1.57%
LLY Eli Lilly and Co1.55%
-- 1.47%
MDT Medtronic PLC1.41%
-- 1.39%
AIG AIG1.33%

Partner Offers